BioSpace News Archive

4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021

4D pharma plc today announces new biomarker analyses from two ongoing clinical trials of its lead immuno-oncology single strain Live Biotherapeutic, MRx0518, in both neoadjuvant and refractory solid tumor settings, at the European Society for Medical Oncology (ESMO) Congress, September 16-21, 2021.

September 15, 2021
·
9 min read
Drug Development

Taysha Gene Therapies Announces Publication of Positive Preclinical Data for TSHA-104 Demonstrating Therapeutic Potential in SURF1-associated Leigh Syndrome in Journal Molecular Therapy: Methods & Clinical Development

Taysha Gene Therapies Announces Publication of Positive Preclinical Data for TSHA-104 Demonstrating Therapeutic Potential in SURF1-associated Leigh Syndrome in Journal Molecular Therapy: Methods & Clinical Development

September 15, 2021
·
6 min read
Drug Development

Biogen Plans to Initiate Phase 3b Study Evaluating Potential Benefit of a Higher Dose of Nusinersen in Patients Previously Treated with Evrysdi® (risdiplam)

Biogen Inc. (Nasdaq: BIIB) today announced plans to initiate a global Phase 3b clinical study, ASCEND.

September 15, 2021
·
11 min read
Business

Rational Vaccines Announces the Appointment of Kerstin Westritschnig, MD, as Chief Medical Officer (CMO)

Rational Vaccines today announced the appointment of Kerstin Westritschnig, MD, as the Company’s chief medical officer (CMO).

September 15, 2021
·
4 min read
Oragenics Initiates COVID-19 Challenge Study Evaluating Multiple Formulations of its SARS-CoV-2 Vaccine Candidate

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced the initiation of a study to evaluate the immunogenicity and viral load reduction impact of its SARS-CoV-2 vaccine candidate in a hamster challenge study.

September 15, 2021
·
4 min read
Business

Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer

Kyverna Therapeutics, Inc., today announced the appointment of Ian Clark as chair of the company’s board of directors and the appointment of Karen Walker as Chief Technology Officer (CTO).

September 15, 2021
·
5 min read
Business

Celularity Appoints Andrew L. Pecora, M.D., F.A.C.P., C.P.E., as President

Celularity Inc., a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic therapies, announced the appointment of Andrew L. Pecora, M.D., F.A.C.P., C.P.E., as President.

September 15, 2021
·
5 min read
Drug Development

Kinaset Therapeutics Announces Dosing Underway in its Phase 1b Study of KN-002 in Healthy Volunteers and Asthma Patients

Kinaset Therapeutics, a biopharmaceutical company developing a next generation anti-inflammatory therapy to treat patients with severe asthma, today announced that the first 24 participants have been dosed in its Phase 1b placebo-controlled study.

September 15, 2021
·
4 min read
NHS AI provider plans public listing following 160% growth

RwHealth, which provides AI solutions to NHS trusts appoints finnCap to facilitate listing.

September 15, 2021
·
3 min read
Business

Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Sparsentan in Europe, Australia and New Zealand

Travere Therapeutics, Inc. (NASDAQ: TVTX) and Vifor Pharma today announced the companies have entered into a joint collaboration and licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand.

September 15, 2021
·
9 min read